Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for IMU-838 in relapsing multiple sclerosis indicates the study is active but not recruiting, with focus on efficacy, safety, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• IMU-838 (IMU-838)

Snippet

Sponsor: Immunic AG | Conditions: Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING